<div class="container">

<table style="width: 100%;"><tr>
<td>metabolic_gofer</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Dataset for building a GOfER diagram (Graphical Overview for Evidence Reviews)</h2>

<h3>Description</h3>

<p>A dataset containing the summary of the studies included in the meta-analysis.
This dataset is used to build a GOfER with 'ggplot2' and 'patchwork'.
</p>


<h3>Usage</h3>

<pre><code class="language-R">metabolic_gofer
</code></pre>


<h3>Format</h3>

<p>A data frame with 115 rows and 33 variables:
</p>

<dl>
<dt>study</dt>
<dd>
<p>last name of first author and year of publication</p>
</dd>
<dt>groups</dt>
<dd>
<p>group allocated in the study, it may be either: HIIT (High-intensity Interval Training), SIT (Sprint Interval Training), or MICT (Moderate-intensity Continuous Training)</p>
</dd>
<dt>sample_population</dt>
<dd>
<p>population category from the study, it may be either: Healthy, Overweight/obese, Cardiac Rehabilitation, Metabolic Syndrome, or T2D (Type-2 Diabetes)</p>
</dd>
<dt>sample_fitness</dt>
<dd>
<p>the general fitness condition of the sample reported in the study, it may be either: Active, Sedentary, or N/R (Not Reported)</p>
</dd>
<dt>sample_men_ratio</dt>
<dd>
<p>the men ratio (total men divided by sample size) reported in the study</p>
</dd>
<dt>anamnese_smoker</dt>
<dd>
<p>information whether participants in the sample were smokers, it may either: Y (Yes), N (No), or N/R (Not Reported)</p>
</dd>
<dt>anamnese_medicines_to_control_BP</dt>
<dd>
<p>information whether participants in the sample were taking regular medication to control blood pressure, it may either: Y (Yes), N (No), or N/R (Not Reported)</p>
</dd>
<dt>age</dt>
<dd>
<p>the age of each group reported in the study, in years</p>
</dd>
<dt>design_type_of_exercise</dt>
<dd>
<p>the type of exercise used for exercise training, it may be either running or cycling</p>
</dd>
<dt>design_sample_size</dt>
<dd>
<p>the sample size of each group in the study</p>
</dd>
<dt>design_training_duration</dt>
<dd>
<p>the training duration, in weeks</p>
</dd>
<dt>design_training_frequency</dt>
<dd>
<p>the training frequency for each group used in the study</p>
</dd>
<dt>design_exercise_intensity</dt>
<dd>
<p>the prescribed exercise intensity for each group</p>
</dd>
<dt>hiie_n_reps</dt>
<dd>
<p>number of repetitions prescribed for the HIIE (High-intensity Interval Exercise) protocol</p>
</dd>
<dt>hiie_rep_duration</dt>
<dd>
<p>length of repetitions prescribed for the HIIE (High-intensity Interval Exercise) protocol</p>
</dd>
<dt>hiie_work_rest_ratio</dt>
<dd>
<p>the work-rest ratio in the HIIE (High-intensity Interval Exercise) protocol</p>
</dd>
<dt>compliance</dt>
<dd>
<p>compliance reported in each group and study</p>
</dd>
<dt>endpoints_vo2max</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on VO2max (maximal oxygen uptake). If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_fmd</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on Flow-mediated Dilation. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_body_mass</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on Body Mass. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_body_fat</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on Body Fat. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_sbp</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on Systolic Blood Pressure. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_dbp</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on Diastolic Blood Pressure. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_hdl</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on HDL. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_ldl</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on LDL. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_triglycerides</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on Triglycerides. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_total_cholesterol</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on Total Cholesterol. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_insulin</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on Fasting Insulin. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_glucose</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on Fasting Glucose. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_homa</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on HOMA-IR (insulin resistance). If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_bmi</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on BMI (body mass index). If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_crp</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on C-reactive Protein. If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
<dt>endpoints_hba1c</dt>
<dd>
<p>information on whether the reported p-value was singificant comparing the effects pre- and post-training on HbA1c (glycated hemoglobin). If Yes, the reported p-value was less than 0.05; if No, the reported p-value was greater than 0.05</p>
</dd>
</dl>
<h3>Source</h3>

<p><a href="https://journals.lww.com/acsm-msse/Fulltext/2021/03000/Effectiveness_of_HIIE_versus_MICT_in_Improving.12.aspx">https://journals.lww.com/acsm-msse/Fulltext/2021/03000/Effectiveness_of_HIIE_versus_MICT_in_Improving.12.aspx</a>
</p>


</div>